Overview
This study used a murine model to demonstrate that prior nickel sensitization induces cross-reactivity with palladium challenge, while chromium sensitization does not. Histological and immunohistochemical analysis of footpad T cells at 1, 3, and 7 days after the third Pd challenge characterized the immune cell populations mediating cross-reactive responses. This mechanistically supports clinical observations of Ni-Pd co-sensitization in humans.
Key numbers
- Three experimental groups: Ni-sensitized/Pd-challenged (Ni-Pd), Cr-sensitized/Pd-challenged (Cr-Pd), saline-sensitized/Pd-challenged control (Saline-Pd)
- n=5 mice per group
- Analysis timepoints: 1, 3, and 7 days after third Pd challenge
- Statistical analysis by Dunn’s test (*p<0.05, **p<0.01)
- Ni-Pd group showed cross-reactive footpad swelling vs Saline-Pd control
- Cr-Pd group did not demonstrate significant cross-reactivity
Methods (brief)
Murine sensitization and challenge protocol with nickel (Ni), chromium (Cr), or saline sensitization followed by Pd challenge. Footpad swelling measured at defined timepoints. Histological sections stained and immunohistochemically labeled for T cell subsets. Statistical comparison between sensitization groups at each timepoint.
Implications
This page makes the source discoverable for palladium evidence routing. Provides direct experimental evidence that Ni sensitization induces immunological cross-reactivity with Pd challenge, while Cr sensitization does not, explaining clinical co-sensitization patterns and informing clinical management of Ni-allergic patients with Pd-containing dental alloys.
Related evidence
Update history
No substantive edit history is available in this build. The full commit record is available in git.